Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.67 million shares were traded. BDTX stock price reached its highest trading level at $2.54 during the session, while it also had its lowest trading level at $2.47.
Ratios:
To gain a deeper understanding of BDTX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.05 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.64. For the most recent quarter (mrq), Quick Ratio is recorded 8.94 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.13.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 19 ’25 when BIOTECH GROWTH N V sold 5,784,292 shares for $2.07 per share. The transaction valued at 11,997,749 led to the insider holds 2,733,547 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BDTX now has a Market Capitalization of 141867536 and an Enterprise Value of 26034534. As of this moment, Black’s Price-to-Earnings (P/E) ratio for their current fiscal year is 6.86. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.03 while its Price-to-Book (P/B) ratio in mrq is 1.12. Its current Enterprise Value per Revenue stands at 0.372 whereas that against EBITDA is 1.719.
Stock Price History:
The Beta on a monthly basis for BDTX is 3.38, which has changed by 0.16355145 over the last 52 weeks, in comparison to a change of 0.17673707 over the same period for the S&P500. Over the past 52 weeks, BDTX has reached a high of $4.94, while it has fallen to a 52-week low of $1.20. The 50-Day Moving Average of the stock is -27.93%, while the 200-Day Moving Average is calculated to be -9.37%.
Shares Statistics:
It appears that BDTX traded 1.20M shares on average per day over the past three months and 890280 shares per day over the past ten days. A total of 56.94M shares are outstanding, with a floating share count of 44.75M. Insiders hold about 21.46% of the company’s shares, while institutions hold 58.80% stake in the company. Shares short for BDTX as of 1765756800 were 6298943 with a Short Ratio of 5.25, compared to 1763078400 on 6356283. Therefore, it implies a Short% of Shares Outstanding of 6298943 and a Short% of Float of 15.870000000000001.
Earnings Estimates
The market rating of Black Diamond Therapeutics Inc (BDTX) is currently shaped by the ongoing analysis conducted by 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.06, with high estimates of $1.03 and low estimates of -$0.22.
Analysts are recommending an EPS of between $0.47 and $0.34 for the fiscal current year, implying an average EPS of $0.42. EPS for the following year is -$0.6, with 6.0 analysts recommending between -$0.19 and -$0.83.
